Ratio Derivative Spectrophotometric Method for the Determination of Some Oxicams in Presence of their Alkaline Degradation Products

Scientia Pharmaceutica

Volumn 71, Issue 4, 2003, Pages 303-320

  Taha, Elham Anwer ^a   El Zanfally, Eman Saad ^b   Salama, Nahla Nour ^a  

^a NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

2 amino 5 methylthiazole; 2 aminopyridine; Dosage forms; Oxicams; Ratio derivative spectrophotometry

Indexed keywords

2 AMINO 5 METHYLTHIAZOLE; 2 AMINOPYRIDINE; LORNOXICAM; MELOXICAM; OXICAM DERIVATIVE; TENOXICAM; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ALKALINITY; ARTICLE; CALIBRATION; DRUG DEGRADATION; DRUG DETERMINATION; DRUG DOSAGE FORM; SEPARATION TECHNIQUE; STATISTICAL ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 0347990679     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.aut-03-26     Document Type: Article

References (24)

1. The Merk Index, 13 th. Ed., Merk and Co. Inc., whitehouse station N. J., USA 2001; 1000.
2. British Pharmacopoeia, Her Majestys Stationary Office, London 2002; 1653, 1110, 2476, 2477.
3. Matindale (The Extra Pharmacopoeia), 33 th. Ed., the Pharmaceutical Press, London 2002; 52.
4. Gilman A G, Limbird L E, Hardman J G. Goodman and Gilman's "The Pharmacological Basis Of Therapeutics" 10 th.Ed. McGraw-Hill, USA 2001; 713.
5. Joseph C J, Bertucat M. Simultaneous high - Performance Liquid Chromatograghy analysis of non-steroidal anti-inflammatory oxicams in Pharmaceutical Preparations. J. Liq. Chromatogr. Relat. Techol 1999; 22(13): 2009-21.
6. Radhofer W S, Dittrich P. Determination of the novel non-steroidal anti-inflammatory drug Lornoxicam and its main metabolite in plasma and synovial fluid. J. of Chromatogr., B: Biomed. Appl. 1998; 707(1-2): 151-9.
7. El-Ries M A. Spectrophotometric determination of piroxicam and tenoxicam in pharmceutical preparations using uranyl acetate as a chromogenic agent. Anal. Lett. 1998; 31 (5): 793-807.
8. Al-Tamrah S A. Flow injection spectrophotometric determination of tenoxicam. Anal. Chim - Acta 1998; 375 (3): 277-83.
9. Taha E A, Salama N N, Abdel Fattah L S. Stability - Indicating methods for determination of meloxicam and tenoxicam in the presence of their degradation products. Spectrosc. Lett. 2002; 35 (4): 501-16.
10. Atay O, Dincol F. Quantitative determination of tenoxicam by infra - red spectrophotometry. Anal. Lett. 1997; 30 (9): 1675-84.
11. Mason J L, Hobbs G J. Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography. J. Chromatog. B. Biomed. Appl. 1995; 665 (2): 410-5.
12. Atkopar Z, Tuncel M. The polarographic determination of tenoxicam in pharmaceutical preparations. Anal. Lett. 1996; 29 (13): 2383-97.
13. Ozaltin N. Differential pulse polarogrraphic determination of tenoxicam in pharmaceuticals and added to blood. Anal. Chim. Acta 2000; 406 (2): 183-9.
14. Khalil S, Borham N, El-Ries M A. Piroxicam and tenoxicam selective membrane sensors. Anal. Chim. Acta 2000; 414 (1-2): 215-9.
15. Sane RT, Surve V, Francis M Extractive colorimetric determination of meloxicam from its pharmaceutical preparation. Indian Drugs 2000; 37 (8): 390-3.
16. Bebawy L I. Stabiity - indicating method for the determination of meloxicam and tetracaine hydrochloride in the presence of their degradation products. Spectrosc. Lett 1998; 31(4): 797-820.
17. Joseph C J, Bertucat M. Determination of meloxicam in tablet formulations by ultraviolet spectrophotometry and high performance liquid chromatography Anal. Lett. 1999; 32 (10): 2051-9.
18. Radi A, El. Ries M A, El-Anwar F, El-Sherif Z. Electrochemical oxidation of meloxicam and its determination in tablet dosage form. Anal. Lett. 2001; 34(5): 739-48.
19. Beltagi A M, Ghoneim M M, Radi A. Electrochemical reduction of meloxicam at mercury electrode and its determination in tablets. J. Pharm. Biomed. Anal. 2000; 27 (5): 795-801.
20. Potentiometry and HPLC manufacturer methods supplied by October Pharm. Co., Egypt by personal communication 1997.
21. Basilio M. Determination of noramidopyrine methane sulphonate sodium salt, pitophenone hydrochloride and fenpiverine bromide in pharmaceuticals by ratio - spectra zero - crossing derivative spectrophotomerty Anal. Lett. 1998; 31 (14): 2431-45.
22. Berzas N J J, Lemus G J M, Castaneda P G. Resolution of ternary mixtures of sulphaquinoxaline, sulphamethazine and pyrimethamine by using the derivative ratio spectrum - zero crossing method. Anal Lett. 1995; 28 (1): 93-107.
23. The European Agency for the Evaluation of Medical Products, ICH Topic Q2B Note for Guidance on Validation of Analytical Procedurers, Methodology. CPMP/ICH/281/95, 1996.
24. Spectrophotometry manufacturer procedure supplied by Adwia Co., Egypt by personal communication 1996.